Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain

Annals of the New York Academy of Sciences

Volumn 865, Issue , 1998, Pages 412-415

  Vertongen, Pascale ^a   Schiffmann, Serge N ^a   Gourlet, Philippe ^a   Robberecht, Patrick ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL TISSUE; AUTORADIOGRAPHY; BRAIN; CONFERENCE PAPER; NONHUMAN; RAT;

ANIMALIA;

EID: 0032431079     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11206.x     Document Type: Conference Paper

References (11)

1. Christophe, J. 1993. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta 1154: 183-199.
2. Ishihara, T. et al. 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8: 811-819.
3. 2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334: 3-8.
4. Besson, J. et al. 1986. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res. 398: 329-336.
5. Sheward, W. J., E. M. Lutz & A. J. Harmar. 1995. The distribution of vasoactive intestinal peptide 2 receptor messenger RNA in the rat brain and pituitary gland as assessed by in situ hybridization. Neurosci. 67: 409-418.
6. Usdin, T. B., T. I. Bonner & E. Mezey. 1994. Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions. Endocrinology 135: 2662-2680.
7. Gourlet, P. et al. 1997. The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides 8: 403-408.
8. O'Donnell, M. et al. 1994. RO 25-1553: a novel long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis. J. Pharmacol. Exp. Ther. 270: 1289-1294.
9. 1 receptor agonists. Peptides 18: 1539-1545.
10. 16 in VIP, PACAP and secretin on ligand affinity for the receptors. Biochim. Biophys. Acta 1314: 267-273.
11. Vertongen, P. et al. 1996. Pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes are differently expressed in rat transplanted pituitary tumours (SMtTW) and in the normal gland. J. Mol. Endocrinol. 16: 239-248.